Use of wuling formulation in the preparation of drug for preventing or treating non-alcoholic fatty liver disease.
OA22325AActive Publication Date: 2026-09-30TSING HUA DE REN XIAN HAPPINESS PHARMA
0 Cites 0 Cited by
Patent Information
- Application Number
- OA1202600040
- Authority / Receiving Office
- OA · OA
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2044-07-11
Abstract
The use of a Wuling formulation in the préparation of a medicament for preventing or treating nonalcoholic fatty liver disease. Effective medicine components of the Wuling formulation comprise radix bupleuri, glossy ganoderma, radix salviae miltiorrhizae and fructus schisandrae chinensis. Said formulation has simple components, but the four medicines are synergistic and play an effective rôle in preventing or treating non-alcoholic fatty liver disease.
Need to check novelty before this filing date? Find Prior Art